Yajuan Qi

Tangshan, 063210, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Linderane, a furanosesquiterpene from Lindera aggregata, targets STAT3 to improve metabolic and inflammatory features of MASLD.

Linderane, a furanosesquiterpene from Lindera aggregata, targets STAT3 to improve metabolic and inflammatory features of MASLD.

Journal: Journal of ethnopharmacology

Published: April 02, 2026

Inflammation-mediated diabetes-liver disease cross-organ crosstalk: From molecular mechanisms to precision therapeutic strategies.

Inflammation-mediated diabetes-liver disease cross-organ crosstalk: From molecular mechanisms to precision therapeutic strategies.

Journal: Life sciences

Published: March 03, 2026

Exosome-Delivered eNAMPT From Exercise Activates SIRT1 to Counteract Age-Related Hepatic Steatosis and Fibrosis.

Exosome-Delivered eNAMPT From Exercise Activates SIRT1 to Counteract Age-Related Hepatic Steatosis and Fibrosis.

Journal: Aging cell

Published: October 07, 2025

Corrigendum to "Yinchen Gongying Decoction mitigates CCl4-induced chronic liver injury and fibrosis in mice implicated in inhibition of the FoxO1/TGF-β1/ Smad2/3 and YAP signaling pathways" [J. Ethnopharmacol. 327 (2024) 117975].

Corrigendum to "Yinchen Gongying Decoction mitigates CCl4-induced chronic liver injury and fibrosis in mice implicated in inhibition of the FoxO1/TGF-β1/ Smad2/3 and YAP signaling pathways" [J. Ethnopharmacol. 327 (2024) 117975].

Journal: Journal of ethnopharmacology

Published: June 10, 2025

Effects of Mao tea from Nankun Mountain on nonalcoholic fatty liver disease in mice.

Effects of Mao tea from Nankun Mountain on nonalcoholic fatty liver disease in mice.

Journal: Food & function

Published: September 09, 2024

Reduction-Responsive Polyprodrug Nanoplatform Based on Curcumin for Tumor-Targeted Therapy.

Reduction-Responsive Polyprodrug Nanoplatform Based on Curcumin for Tumor-Targeted Therapy.

Journal: Current drug delivery

Published: March 31, 2024

Yinchen gongying decoction mitigates CCl4-induced chronic liver injury and fibrosis in mice implicated in inhibition of the FoxO1/TGF-β1/ Smad2/3 and YAP signaling pathways.

Yinchen gongying decoction mitigates CCl4-induced chronic liver injury and fibrosis in mice implicated in inhibition of the FoxO1/TGF-β1/ Smad2/3 and YAP signaling pathways.

Journal: Journal of ethnopharmacology

Published: December 17, 2023

Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation.

Hepatocyte FoxO1 Deficiency Protects From Liver Fibrosis via Reducing Inflammation and TGF-β1-mediated HSC Activation.

Journal: Cellular and molecular gastroenterology and hepatology

Published: March 24, 2023

Redox-responsive Nanomicelles with Intracellular Targeting and Programmable Drug Release for Targeted Tumor Therapy.

Redox-responsive Nanomicelles with Intracellular Targeting and Programmable Drug Release for Targeted Tumor Therapy.

Journal: Current drug delivery

Published: January 29, 2023

Liver knockout YAP gene improved insulin resistance-induced hepatic fibrosis.

Liver knockout YAP gene improved insulin resistance-induced hepatic fibrosis.

Journal: The Journal of endocrinology

Published: March 17, 2021

Protective effects of rutin on kidney in type 1 diabetic mice.

Protective effects of rutin on kidney in type 1 diabetic mice.

Journal: Pakistan journal of pharmaceutical sciences

Published: April 12, 2020

Baihe Wuyao decoction ameliorates CCl4-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects.

Baihe Wuyao decoction ameliorates CCl4-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects.

Journal: Journal of ethnopharmacology

Published: November 25, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026